BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27474929)

  • 1. In vitro and in vivo studies of the antineoplastic activity of copper (II) compounds against human leukemia THP-1 and murine melanoma B16-F10 cell lines.
    Borges LJH; Bull ÉS; Fernandes C; Horn A; Azeredo NF; Resende JALC; Freitas WR; Carvalho ECQ; Lemos LS; Jerdy H; Kanashiro MM
    Eur J Med Chem; 2016 Nov; 123():128-140. PubMed ID: 27474929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis in leukemia cell lines by new copper(II) complexes containing naphthyl groups via interaction with death receptors.
    Fernandes C; Horn A; Lopes BF; Bull ES; Azeredo NFB; Kanashiro MM; Borges FV; Bortoluzzi AJ; Szpoganicz B; Pires AB; Franco RWA; Almeida JCA; Maciel LLF; Resende JALC; Schenk G
    J Inorg Biochem; 2015 Dec; 153():68-87. PubMed ID: 26485179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the hydroxamate group in the antitumoral activity and toxicity toward normal cells of new copper(II) complexes.
    Azeredo NFB; Borges FV; Mathias MS; Resende JALC; Franco RWA; Kanashiro MM; Horn A; Fernandes C
    Biometals; 2021 Apr; 34(2):229-244. PubMed ID: 33559811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).
    Qin QP; Liu YC; Wang HL; Qin JL; Cheng FJ; Tang SF; Liang H
    Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumoral synergism between a copper(II) complex and cisplatin improves in vitro and in vivo anticancer activity against melanoma, lung and breast cancer cells.
    Mariani D; Ghasemishahrestani Z; Freitas W; Pezzuto P; Costa-da-Silva AC; Tanuri A; Kanashiro MM; Fernandes C; Horn A; Pereira MD
    Biochim Biophys Acta Gen Subj; 2021 Oct; 1865(10):129963. PubMed ID: 34246719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly efficient synthetic iron-dependent nucleases activate both intrinsic and extrinsic apoptotic death pathways in leukemia cancer cells.
    Horn A; Fernandes C; Parrilha GL; Kanashiro MM; Borges FV; de Melo EJ; Schenk G; Terenzi H; Pich CT
    J Inorg Biochem; 2013 Nov; 128():38-47. PubMed ID: 23933562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo anti-proliferative evaluation of bis(4'-(4-tolyl)-2,2':6',2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors.
    Mahendiran D; Kumar RS; Viswanathan V; Velmurugan D; Rahiman AK
    J Biol Inorg Chem; 2017 Oct; 22(7):1109-1122. PubMed ID: 28884428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
    Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
    Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
    Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new synthetic Cu(II) compound, [Cu3(p-3-bmb)2Cl4·(CH3OH)2]n, inhibits tumor growth in vivo and in vitro.
    Li R; Cui B; Li Y; Zhao C; Jia N; Wang C; Wu Y; Wen A
    Eur J Pharmacol; 2014 Feb; 724():77-85. PubMed ID: 24365492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effects of copper(II)-polypyridyl complexes in breast cancer cells through inducing apoptosis.
    Salimi M; Abdi K; Kandelous HM; Hadadzadeh H; Azadmanesh K; Amanzadeh A; Sanati H
    Biometals; 2015 Apr; 28(2):267-78. PubMed ID: 25673217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
    Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
    J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer activity and DNA-binding investigations of the Cu(II) and Ni(II) complexes with coumarin derivative.
    Zhu T; Wang Y; Ding W; Xu J; Chen R; Xie J; Zhu W; Jia L; Ma T
    Chem Biol Drug Des; 2015 Mar; 85(3):385-93. PubMed ID: 25141910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic activity of novel palladium-based compounds on leukemia cell lines.
    Antunovic M; Kriznik B; Ulukaya E; Yilmaz VT; Mihalic KC; Madunic J; Marijanovic I
    Anticancer Drugs; 2015 Feb; 26(2):180-6. PubMed ID: 25280061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ternary copper(II) complexes with amino acid chains and heterocyclic bases: DNA binding, cytotoxic and cell apoptosis induction properties.
    Ma T; Xu J; Wang Y; Yu H; Yang Y; Liu Y; Ding W; Zhu W; Chen R; Ge Z; Tan Y; Jia L; Zhu T
    J Inorg Biochem; 2015 Mar; 144():38-46. PubMed ID: 25555321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,6-Bis(2,6-diethylphenyliminomethyl)pyridine coordination compounds with cobalt(II), nickel(II), copper(II), and zinc(II): synthesis, spectroscopic characterization, X-ray study and in vitro cytotoxicity.
    Martinez-Bulit P; Garza-Ortíz A; Mijangos E; Barrón-Sosa L; Sánchez-Bartéz F; Gracia-Mora I; Flores-Parra A; Contreras R; Reedijk J; Barba-Behrens N
    J Inorg Biochem; 2015 Jan; 142():1-7. PubMed ID: 25282405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper(II) mixed chelate compounds induce apoptosis through reactive oxygen species in neuroblastoma cell line CHP-212.
    Gutiérrez AG; Vázquez-Aguirre A; García-Ramos JC; Flores-Alamo M; Hernández-Lemus E; Ruiz-Azuara L; Mejía C
    J Inorg Biochem; 2013 Sep; 126():17-25. PubMed ID: 23727332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly cytotoxic DNA-interacting copper(II) coordination compounds.
    Brissos RF; Torrents E; dos Santos Mello FM; Carvalho Pires W; Silveira-Lacerda Ede P; Caballero AB; Caubet A; Massera C; Roubeau O; Teat SJ; Gamez P
    Metallomics; 2014 Oct; 6(10):1853-68. PubMed ID: 25096758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating the antitumoral activity by the design of new platinum(II) compounds: Synthesis, characterization, DFT, ultrastructure and mechanistic studies.
    Moreira RO; Morcelli SR; Kanashiro MM; Resende JALC; Maciel LLF; de A Almeida JC; Gahan LR; Horn A; Fernandes C
    J Inorg Biochem; 2019 May; 194():200-213. PubMed ID: 30877895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, crystal structure, and cytotoxic activity of novel cyclic systems in [1,2,4]thiadiazolo[2,3-a]pyridine benzamide derivatives and their copper(II) complexes.
    Adhami F; Safavi M; Ehsani M; Ardestani SK; Emmerling F; Simyari F
    Dalton Trans; 2014 Jun; 43(21):7945-57. PubMed ID: 24715093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.